PTC Therapeutics Inc (PTCT) — Cash Flow Quality Index

Latest as of September 2025: -4.17x

PTC Therapeutics Inc (PTCT) has a Cash Flow Quality Index of -4.17x as of September 2025. Operating cash flow of $-66.30 Million is below net income of $15.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PTCT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-4.17x
Operating CF / Net Income

Operating Cash Flow

$-66.30 Million
USD

Net Income

$15.90 Million
USD

Data as of

Sep 2025
Most recent filing

PTC Therapeutics Inc Cash Flow Quality Index (2011–2025)

Historical Cash Flow Quality Index for PTC Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see PTC Therapeutics Inc cash conversion from operations.

Annual Cash Flow Quality Index for PTC Therapeutics Inc (2011–2025)

Year-by-year earnings quality comparison for PTC Therapeutics Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2025 1.04x $711.20 Million $682.64 Million ▲ +255.0%
2011 -0.67x $-20.77 Million $30.90 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.